Feed ANGO
AN

AngioDynamics, Inc.

ANGO · NASDAQ

$15.46 -1.40% (-$0.22)
1M -2.28%
Market Cap $639.0M
P/E Ratio -
Div. Yield -
ROE 21.01%

Bulios Fair Price

$7.91

48.8% downside

Current Price

$15.46

Undervalued Fair Value Overvalued

According to Bulios Fair Price, ANGO is currently overvalued relative to its market price. How does it work?

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Piotroski F-Score Moderate
5/9
Valuation
29 /100
Expensive
P/S 2.00x
P/FCF 1,257.87x
P/B 3.74x
Growth
9 /100
Declining
Rev. growth 1.86%
Book val. growth 23.28%
EPS growth N/A
Profitability
22 /100
Weak
Gross margin 54.62%
FCF margin 0.16%
Net margin 11.48%
Quality
15 /100
Poor
ROIC 21.00%
Asset turnover 1.20x
ROE 21.01%
Debt
69 /100
Low
Debt/Equity 0.00x
Int. coverage -120.41x
Current ratio 2.19x
Stability
36 /100
Moderate
Beta 0.33x
Profitable years 0
Rev. volatility 10.06%

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about ANGO
Online

About the company

AngioDynamics, Inc. (ANGO) is an American company operating in the field of medical technologies, specifically in vascular and oncological surgery. With over 30 years of experience, AngioDynamics is a leading player in the medical sector. The company offers a wide range of products, from catheters to laser systems for tumor treatment. It is known for its commitment to innovation and clinical excellence. AngioDynamics, Inc. (ANGO) shares could be suitable for investors looking to invest in a rapidly growing and innovative healthcare sector.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

CEO

James C. Clemmer

Employees

632

Headquarters

Latham

Upcoming events

01 OCT

Earnings

Upcoming earnings report

14d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.